ライフサイエンスコーパス: Streptococcus pneumoniae

1 rata, 2 coagulase-negative Staphylococcus, 1 Streptococcus pneumoniae).

2 icobacter pylori, Moraxella catarrhalis, and Streptococcus pneumoniae.

3 ntibiotic resistance in both V. cholerae and Streptococcus pneumoniae.

4 enzyme LicC, which is a virulence factor in Streptococcus pneumoniae.

5 ia meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae.

6 were collected and cultured for isolation of Streptococcus pneumoniae.

7 (OVA) and then infected with M pneumoniae or Streptococcus pneumoniae.

8 ia, including the major respiratory pathogen Streptococcus pneumoniae.

9 cell wall biosynthesis and cell division of Streptococcus pneumoniae.

10 PD and challenged with opsonized serotype 14 Streptococcus pneumoniae.

11 so abrogating the virulence of the pathogen Streptococcus pneumoniae.

12 Th) 17 cells are important in the control of Streptococcus pneumoniae.

13 concept of this approach for 2 serotypes of Streptococcus pneumoniae.

14 logous stimulation with Escherichia coli and Streptococcus pneumoniae.

15 owth of the major human respiratory pathogen Streptococcus pneumoniae.

16 y erm(B) confer most macrolide resistance in Streptococcus pneumoniae.

17 es was correlated with relative abundance of Streptococcus pneumoniae.

18 e the agglutination of specific serotypes of Streptococcus pneumoniae.

19 man respiratory mucus and the human pathogen Streptococcus pneumoniae.

20 requently identified organism on culture was Streptococcus pneumoniae.

21 t transcription waves defining competence in Streptococcus pneumoniae.

22 mice, and the airway was then infected with Streptococcus pneumoniae.

23 gnificantly increased for nonneonates, while Streptococcus pneumoniae (1.07 to 0.26) and Enterococcus

24 an herpesvirus 6; 2 group B Streptococcus; 2 Streptococcus pneumoniae; 1 HSV; 1 parechovirus; 1 enter

25 were Staphylococcus aureus (34/37 [91.9%]), Streptococcus pneumoniae (10/11 [90.9%]), and Enterobact

26 re used to test 10 Staphylococcus aureus, 10 Streptococcus pneumoniae, 10 Haemophilus influenzae, and

27 operative bile and wound infection cultures (Streptococcus pneumoniae, 114 cultures [47.9%] in instit

28 (15.6%), Klebsiella pneumoniae (15.6%), and Streptococcus pneumoniae (12.5%).

29 uses were group B streptococcus 25% (16-33), Streptococcus pneumoniae 17% (9-6), and S aureus 12% (3-

30 ys, we estimate 40,600 pneumonia deaths from Streptococcus pneumoniae, 20,700 from RSV, 12,600 from i

31 The most common blood culture isolates were Streptococcus pneumoniae (24.9%), Staphylococcus aureus

32 Among bacteria Streptococcus pneumoniae (31.1%, N = 14) was isolated in

33 ), whereas blood cultures most commonly grew Streptococcus pneumoniae (33%), followed by S. aureus (2

34 ogens were Klebsiella pneumoniae (86 [31%]), Streptococcus pneumoniae (54 [20%]), HIV (40 [15%]), and

35 Streptococcus pneumoniae (9/44 [20%]) and Staphylococcus

36 detected among the 126 confirmed cases were Streptococcus pneumoniae (93 [73.8%]), Haemophilus influ

37 The most common pathogens were Streptococcus pneumoniae (93 of 143, 65%) and Haemophilu

38 ogen found in bacterial superinfection, with Streptococcus pneumoniae a close second.

39 ryngeal infection by S. pyogenes, but not by Streptococcus pneumoniae, a bacterium that does not prod

40 ing on mitochondrial function in response to Streptococcus pneumoniae, a causative agent of bacterial

41 substantially reduced disease burden due to Streptococcus pneumoniae, a leading cause of childhood m

42 Streptococcus pneumoniae, a normal commensal of the uppe

43 opportunistic pathogens Escherichia coli and Streptococcus pneumoniae across European countries and t

44 SnoopLigase was engineered from a Streptococcus pneumoniae adhesin and enables isopeptide

45 We describe here how Streptococcus pneumoniae adopts a strategy to prevent th

46 Catabolism of galactose by Streptococcus pneumoniae alters the microbe's metabolism

47 Such has been the case with Streptococcus pneumoniae, an important human pathogen, a

48 Natural genetic transformation of Streptococcus pneumoniae, an important human pathogen, m

49 evolution, transmission and pathogenesis of Streptococcus pneumoniae, an opportunistic human-adapted

50 ested at the SSL, 154 were positive with 80% Streptococcus pneumoniae and 20% other bacteria.

51 he pneumonococcal capsular polysaccharide of Streptococcus pneumoniae and against the AD-2S1 peptide

52 ureus in keratitis; Streptococcus viridians, Streptococcus pneumoniae and Coagulase negative Staphylo

53 States for instance, Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae are

54 ated killing enhanced pulmonary clearance of Streptococcus pneumoniae and Haemophilus influenzae in w

55 hood mortality and morbidity attributable to Streptococcus pneumoniae and Haemophilus influenzae type

56 R events in the gram-positive human pathogen Streptococcus pneumoniae and in the human genome.

57 between the opportunistic bacterial pathogen Streptococcus pneumoniae and its human host is its abili

58 atory infection by the major human pathogens Streptococcus pneumoniae and Klebsiella pneumoniae.

59 that is also conserved in pathogens such as Streptococcus pneumoniae and Mycobacterium tuberculosis

60 iotic susceptibility and resistance for both Streptococcus pneumoniae and Neisseria gonorrhoeae.

61 nomic datasets of two major human pathogens, Streptococcus pneumoniae and Neisseria meningitidis, rev

62 Coinfections by Streptococcus pneumoniae and nontypeable Haemophilus inf

63 us aureus, Coagulase negative Staphylococci, Streptococcus pneumoniae and Pseudomonas aeruginosa are

64 ng affects both susceptibility to subsequent Streptococcus pneumoniae and Staphylococcus aureus infec

65 were diagnosed with influenza or bacterial (Streptococcus pneumoniae and Staphylococcus aureus) etio

66 Common causative organisms are Streptococcus pneumoniae and Staphylococcus aureus.

67 puncture or infection by Escherichia coli or Streptococcus pneumoniae) and endotoxaemia.

68 acillus subtilis, Listeria monocytogenes and Streptococcus pneumoniae) and suggest their importance f

69 dies, 19 met inclusion criteria (12 assessed Streptococcus pneumoniae) and were used for qualitative

70 lin (Ig) levels, specific antibodies against Streptococcus pneumoniae, and allergen-specific IgE, as

71 stillation of MS-WF, mice were infected with Streptococcus pneumoniae, and bronchoalveolar lavage flu

72 kin 17A (IL-17A) response against colonizing Streptococcus pneumoniae, and its transition to a pathog

73 coli derived lipopolysaccharide, heat-killed Streptococcus pneumoniae, and Mycobacterium tuberculosis

74 s agalactiae, Streptococcus anginosus group, Streptococcus pneumoniae, and Streptococcus pyogenes), p

75 histoplasmosis; pneumonia (viral, bacterial, Streptococcus pneumoniae, and unspecified pneumonia); in

76 e closely related Streptococcus pyogenes and Streptococcus pneumoniae, and while research on GBS TCSs

77 gate vaccine (PCV) antibiotic-nonsusceptible Streptococcus pneumoniae (ANSP) carriage: reduction of P

78 Respiratory viruses and Streptococcus pneumoniae are known to be copathogens in

79 ify HAMLET's bacterial targets, here we used Streptococcus pneumoniae as a model organism and employe

80 terococcus faecalis ATCC 29212 (broth only), Streptococcus pneumoniae ATCC 49619 (disk and broth), an

81 chia coli ATCC 25922, 0.12 to 0.5 mug/ml for Streptococcus pneumoniae ATCC 49619, and 0.12 to 1 mug/m

82 methicillin-resistant Staphylococcus aureus, Streptococcus pneumoniae, beta-hemolytic streptococci, v

83 occus sp. was associated with qPCR levels of Streptococcus pneumoniae but dominance could not be pred

84 lla catarrhalis, Haemophilus influenzae, and Streptococcus pneumoniae, but not other bacterial pathog

85 ort in species such as Bacillus subtilis and Streptococcus pneumoniae, but whether this same mechanis

86 of pneumolysin, the main virulence factor of Streptococcus pneumoniae, by cryoEM.

87 nce and vaccine escape in the human pathogen Streptococcus pneumoniae can be largely attributed to co

88 Streptococcus pneumoniae can cause disease in various hu

89 In mice, Streptococcus pneumoniae can invade the myocardium, indu

90 reducing end, which is the case for ~75% of Streptococcus pneumoniae capsules.

91 ral infections, but the impact of viruses on Streptococcus pneumoniae carriage prevalence and load re

92 Before 1945, Streptococcus pneumoniae caused more than 90% of cases o

93 Streptococcus pneumoniae causes high mortality as a majo

94 screen for mutations affecting the growth of Streptococcus pneumoniae cells when the aPBP synthase PB

95 Streptococcus pneumoniae choline kinase (sChoK) has prev

96 itu the H(2)O(2) concentrations generated by Streptococcus pneumoniae clinical isolates.

97 Control of Streptococcus pneumoniae colonisation at human mucosal s

98 ens, Streptococcus sanguinis (ComGC(SS)) and Streptococcus pneumoniae (ComGC(SP)), revealing that thi

99 Streptococcus pneumoniae commonly inhabits the nasophary

100 In Streptococcus pneumoniae, competence develops transientl

101 ring formation in the ovoid-shaped pathogen, Streptococcus pneumoniae Conventional and single-molecul

102 this study, we use glycoconjugates of type 3 Streptococcus pneumoniae CPS (Pn3P) to assess whether th

103 with positive UAT more often had a positive Streptococcus pneumoniae culture (25.4% vs 1.9%, P < .00

104 peptidoglycan from the midcells of dividing Streptococcus pneumoniae D39 background cells.

105 The respiratory pathogen Streptococcus pneumoniae deploys type IV pili to take up

106 Listeria innocua, Pseudomonas aeruginosa and Streptococcus pneumoniae did not interfere the detection

107 e question of whether the bacterial pathogen Streptococcus pneumoniae directly interferes with purine

108 higher in a Type I diabetic rabbit model of Streptococcus pneumoniae endophthalmitis.

109 m various pathogens (eg, influenza virus and Streptococcus pneumoniae), especially for pathogens whos

110 Streptococcus pneumoniae expresses capsular polysacchari

111 In addition, in vivo infection with Streptococcus pneumoniae failed to induce PU.1 expressio

112 Reduction in yield of Streptococcus pneumoniae from NP culture was approximate

113 est and MALDI-TOF for the differentiation of Streptococcus pneumoniae from other mitis group streptoc

114 ve anaerobe and opportunistic human pathogen Streptococcus pneumoniae generates large amounts of hydr

115 ding proteins that Staphylococcus aureus and Streptococcus pneumoniae, Gram-positive bacterial pathog

116 uncil Unit The Gambia, for identification of Streptococcus pneumoniae, Haemophilus influenzae, and Ne

117 and Acanthamoeba), six bacterial pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Neisse

118 Streptococcus pneumoniae has demonstrated a remarkable a

119 vaccines against Haemophilus influenzae and Streptococcus pneumoniae has virtually eliminated the co

120 We determine that 1-3% of mutants in Streptococcus pneumoniae have a different fitness when g

121 Previous studies in Streptococcus pneumoniae have shown that hsdS inversions

122 gold-standard culture-independent assays for Streptococcus pneumoniae identification.

123 ies and provides a general strategy to block Streptococcus pneumoniae IgA1 protease activity to poten

124 copy single particle reconstructions how the Streptococcus pneumoniae IgA1 protease facilitates IgA1

125 Specifically, the Streptococcus pneumoniae IgA1 protease subscribes to an

126 d transmission of the opportunistic pathogen Streptococcus pneumoniae in an infant mouse model.

127 g the efficacy of geOMVs as vaccines against Streptococcus pneumoniae in mice, and against Campylobac

128 Culture-based methods for detecting Streptococcus pneumoniae in the nasopharynx lack sensiti

129 ing of the spleen, we identify a tropism for Streptococcus pneumoniae in this organ mediated by tissu

130 Infections caused by Streptococcus pneumoniae-including invasive pneumococcal

131 ncoding the only PP2C Ser/Thr phosphatase in Streptococcus pneumoniae, indicating that GpsB plays a k

132 e vaccine (Prevnar-13) against the bacterium Streptococcus pneumoniae induced immune responses that w

133 esults were demonstrated in a mouse model of Streptococcus pneumoniae-induced empyema.

134 of the alveolar barrier in a mouse model of Streptococcus pneumoniae-induced pneumonia, and ex vivo

135 Streptococcus pneumoniae infection can result in bactere

136 th influenza, mice are better protected from Streptococcus pneumoniae infection due to a population o

137 the mechanistic effects of these factors on Streptococcus pneumoniae infection in mice.

138 cortical impact model followed by secondary Streptococcus pneumoniae infection in mice.

139 Secondary Streptococcus pneumoniae infection is a significant caus

140 re, we used a murine model of intrapulmonary Streptococcus pneumoniae infection to investigate the ro

141 cture or bacteremia with Escherichia coli or Streptococcus pneumoniae infection).

142 es in cerebrospinal fluid from children with Streptococcus pneumoniae infection, compared with childr

143 ssociated with virulence in a mouse model of Streptococcus pneumoniae infection.

144 esponses of AMs and exaggerated responses to Streptococcus pneumoniae infection.

145 Streptococcus pneumoniae infections arising in hospitali

146 Streptococcus pneumoniae infections in Taiwan mostly occ

147 Measures of the contribution of influenza to Streptococcus pneumoniae infections, both in the seasona

148 ia meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae, inflicts a substantial burden

149 The Streptococcus pneumoniae Invasive Disease network (SpIDn

150 s in the pre-PCV period, 34% were mixed with Streptococcus pneumoniae IRRs (95% confidence interval)

151 Streptococcus pneumoniae is a common colonizer of the hu

152 Streptococcus pneumoniae is a common nasopharyngeal colo

153 Streptococcus pneumoniae is a devastating global pathoge

154 SP_0782 from Streptococcus pneumoniae is a dimeric protein that poten

155 Streptococcus pneumoniae is a leading cause of invasive

156 Streptococcus pneumoniae is a leading cause of pneumonia

157 Streptococcus pneumoniae is a leading cause of pneumonia

158 Streptococcus pneumoniae is a major cause of community-a

159 Streptococcus pneumoniae is a major cause of life-threat

160 Streptococcus pneumoniae is a major cause of pneumonia,

161 Streptococcus pneumoniae is a major human pathogen that

162 Streptococcus pneumoniae is a major respiratory pathogen

163 Streptococcus pneumoniae is a natural colonizer of the h

164 Streptococcus pneumoniae is a significant cause of otiti

165 Serotype-specific protection against Streptococcus pneumoniae is an important limitation of t

166 The exopolysaccharide capsule of Streptococcus pneumoniae is an important virulence facto

167 Streptococcus pneumoniae is an opportunistic human patho

168 Streptococcus pneumoniae is an opportunistic human patho

169 Streptococcus pneumoniae is an opportunistic respiratory

170 Pulmonary infection by Streptococcus pneumoniae is characterized by a robust al

171 tend our knowledge on the mechanisms whereby Streptococcus pneumoniae is cleared by the spleen.

172 at the activation of macrophage NF-kappaB by Streptococcus pneumoniae is highly diverse, with a prepo

173 Streptococcus pneumoniae is one of the world's leading b

174 Streptococcus pneumoniae is responsible for diseases cau

175 Streptococcus pneumoniae is responsible for severe infec

176 Streptococcus pneumoniae is responsible for the majority

177 Streptococcus pneumoniae is the main bacterial pathogen

178 Streptococcus pneumoniae is the main cause of bacterial

179 Streptococcus pneumoniae is the most common bacterial et

180 Streptococcus pneumoniae is the most common cause of com

181 Streptococcus pneumoniae is the most common cause of pne

182 cial cell wall constituent of the pathobiont Streptococcus pneumoniae, is bound to peptidoglycan (wal

183 We analyzed whole genome sequences of 1,680 Streptococcus pneumoniae isolates from four independent

184 phis infected with the common lung pathogens Streptococcus pneumoniae, Legionella pneumophila, or Myc

185 Streptococcus pneumoniae, like many other naturally tran

186 ith Escherichia coli, Klebsiella pneumoniae, Streptococcus pneumoniae, lipopolysaccharide (LPS), or a

187 For Streptococcus pneumoniae, lower than predicted rates of

188 age with blood culture-proven sepsis due to Streptococcus pneumoniae, meeting criteria for systemic

189 Streptococcus pneumoniae meningitis decreased from 34 in

190 spine surgery was associated with increased Streptococcus pneumoniae meningitis outside of the posto

191 fection on bacterial carriage and density of Streptococcus pneumoniae, Moraxella catarrhalis, Haemoph

192 se bacterial species: Staphylococcus aureus, Streptococcus pneumoniae, Mycobacterium tuberculosis, Sa

193 ), human herpesvirus 6 (HHV-6) (n = 30), and Streptococcus pneumoniae (n = 14).

194 n = 70, 21%), Plasmodium (n = 35, 10%), and Streptococcus pneumoniae (n = 31, 9%).

195 ry identification and serotyping/grouping of Streptococcus pneumoniae, N. meningitidis, and H. influe

196 etermine a structural envelope of SpNOX, the Streptococcus pneumoniae NADPH oxidase (NOX), a prokaryo

197 An increase in Streptococcus pneumoniae nasopharynx (NP) colonization d

198 Streptococcus pneumoniae, Neisseria meningitidis, and Ha

199 Nonencapsulated Streptococcus pneumoniae (NESp) isolates increased among

200 ls were stimulated in vitro with heat-killed Streptococcus pneumoniae or CD3/CD28 antibodies and stai

201 ere was no change in colonization rates with Streptococcus pneumoniae or Neisseria meningitidis.

202 l infections, primarily pneumonias caused by Streptococcus pneumoniae or Staphylococcus aureus.

203 Neisseria meningitidis, Streptococcus pneumoniae, or Haemophilus influenzae case

204 intratracheally with Klebsiella pneumoniae, Streptococcus pneumoniae, or lipopolysaccharide.

205 al [CI] = 3.27-5.37; n = 2432 participants), Streptococcus pneumoniae otitis media (OR = 2.51; 95% CI

206 a three-dimensional structure of the related Streptococcus pneumoniae PBP2X suggests that some substi

207 eumolysin (PLY), a major virulence factor of Streptococcus pneumoniae, perforates cholesterol-rich li

208 Streptococcus pneumoniae (Pnc) serotypes differ in invas

209 Streptococcus pneumoniae (pneumococcus) causes multiple

210 Streptococcus pneumoniae (pneumococcus) is a leading cau

211 Streptococcus pneumoniae (pneumococcus) is a major human

212 Streptococcus pneumoniae (pneumococcus) is a principal c

213 Streptococcus pneumoniae (pneumococcus) is an oval-shape

214 Streptococcus pneumoniae (pneumococcus) is the primary c

215 Streptococcus pneumoniae (pneumococcus) produces many ca

216 n Abidjan, targeting the main causes of PBM: Streptococcus pneumoniae (pneumococcus), Haemophilus inf

217 Identification of Streptococcus pneumoniae (pneumococcus), Haemophilus inf

218 Streptococcus pneumoniae (pneumococcus), Neisseria menin

219 etwork, Togo conducts surveillance targeting Streptococcus pneumoniae (pneumococcus), Neisseria menin

220 Identification of Streptococcus pneumoniae (pneumococcus), Neisseria menin

221 In Streptococcus pneumoniae (pneumococcus), transformation

222 ant polysaccharide conjugate vaccine against Streptococcus pneumoniae (pneumococcus).

223 e-wall like) peptidoglycan (PG) synthesis in Streptococcus pneumoniae (pneumococcus); yet, mechanisms

224 These studies tested the role of Nrf2 during Streptococcus pneumoniae pneumonia and identified Nrf2-d

225 Streptococcus pneumoniae produces pneumolysin toxin as a

226 ediated hemolysis of ES PspCN, a CFH-binding Streptococcus pneumoniae protein domain, binds CFH tight

227 Several Streptococcus pneumoniae proteins play a role in pathoge

228 Streptococcus pneumoniae remains a leading cause of pedi

229 Pneumococcus (Streptococcus pneumoniae) remains a significant cause of

230 exposure was shortened in PCT subjects with Streptococcus pneumoniae respiratory infection and those

231 on of infant rats with increasing inocula of Streptococcus pneumoniae resulted in a dose-dependent in

232 hepatitis B, Haemophilus influenzae type b, Streptococcus pneumoniae, rotavirus, measles, meningitis

233 The lowest IE prevalence was found with Streptococcus pneumoniae (S pneumoniae) 1.2% (0.8-1.6) a

234 Neisseria meningitidis (N. meningitidis), Streptococcus pneumoniae (S. pneumoniae), and Haemophilu

235 tion of Staphylococcus aureus (S. aureus) or Streptococcus pneumoniae (S. pneumoniae), respectively;

236 Opportunistic pathogens such as Streptococcus pneumoniae secrete a giant metalloprotease

237 In oval-shaped Streptococcus pneumoniae, septal and longitudinal peptid

238 In addition, they show high efficiency in Streptococcus pneumoniae septicemia mouse model and neut

239 Streptococcus pneumoniae serotype 1 is one of the leadin

240 Streptococcus pneumoniae serotype 1 is the predominant c

241 verified here for Shigella sonnei O-antigen, Streptococcus pneumoniae serotype 12F, and Staphylococcu

242 nvasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae serotype 2 (Sp2) is infrequent.

243 Using the Streptococcus pneumoniae serotype 2 CPS, which is synthe

244 Streptococcus pneumoniae serotype 3 strains emerge frequ

245 Streptococcus pneumoniae serotype 35B is a nonvaccine se

246 eak was due to multiple pathogens, including Streptococcus pneumoniae serotype 5 and influenza viruse

247 Identifying Streptococcus pneumoniae serotypes by urinary antigen de

248 ble PCR primers were designed to distinguish Streptococcus pneumoniae serotypes within serogroup 18 f

249 were co-infected with influenza A virus and Streptococcus pneumoniae seven days apart.

250 ting invasive pneumococcal disease caused by Streptococcus pneumoniae Some components of the S. pneum

251 cations for urinary antigen tests (UATs) for Streptococcus pneumoniae (SP) and Legionella pneumophila

252 Populations of Streptococcus pneumoniae (SP) are typically structured i

253 Streptococcus pneumoniae (SP) is a pathogenic bacterium

254 ly cover only 13 of the over 90 serotypes of Streptococcus pneumoniae (Sp), so nonvaccine serotypes a

255 ulence of important human pathogens, such as Streptococcus pneumoniae (Sp).

256 -induced lysis of the Gram-positive pathogen Streptococcus pneumoniae (Sp).

257 onfirmed: Neisseria meningitidis ([Nm] 85%), Streptococcus pneumoniae ([Sp] 13%), and Haemophilus inf

258 Streptococcus pneumoniae (Spn) colonizes the nasopharynx

259 Streptococcus pneumoniae (Spn) is a common cause of resp

260 Streptococcus pneumoniae (Spn) is an important Gram-posi

261 Streptococcus pneumoniae (Spn) must acquire iron from th

262 Colonization of the nasopharynx with Streptococcus pneumoniae (Spn), although a prerequisite

263 ibe the epidemiology of laboratory-confirmed Streptococcus pneumoniae (Spn), Neisseria meningitidis,

264 In ovoid-shaped Streptococcus pneumoniae (Spn), septal and peripheral (e

265 mycin did not significantly affect levels of Streptococcus pneumoniae, Staphylococcus aureus, Pseudom

266 teria monocytogenes, Neisseria meningitidis, Streptococcus pneumoniae, Streptococcus agalactiae, cyto

267 nsed vaccines against the common otopathogen Streptococcus pneumoniae target the bacterial capsular p

268 Streptococcus pneumoniae (the pneumococcus) is a common

269 Streptococcus pneumoniae (the pneumococcus) is a human p

270 Streptococcus pneumoniae (the pneumococcus) is a major c

271 Streptococcus pneumoniae (the pneumococcus) is the leadi

272 Even in the vaccine era, Streptococcus pneumoniae (the pneumococcus) remains a le

273 s is a prerequisite for the human pathobiont Streptococcus pneumoniae (the pneumococcus) to cause sev

274 he case for the opportunistic human pathogen Streptococcus pneumoniae (the pneumococcus)(6), which la

275 Streptococcus pneumoniae, the first known transformable

276 In the human respiratory pathogen Streptococcus pneumoniae, the Mn-specific importer PsaBC

277 e show that sublethal infection of mice with Streptococcus pneumoniae, the most common pathogen of co

278 In a number of bacterial species, including Streptococcus pneumoniae, the prevalence of resistance h

279 erotyping assay that uses culture lysates of Streptococcus pneumoniae This study describes the develo

280 n of asymptomatic nasopharyngeal carriage of Streptococcus pneumoniae to invasive pneumococcal diseas

281 The capacity of Streptococcus pneumoniae to successfully transmit and co

282 ative data for the pattern of disease due to Streptococcus pneumoniae, trends in the serotype of inva

283 related to the capsular polysaccharide from Streptococcus pneumoniae type 37, which consists of a be

284 Etiology was defined by blood culture, Streptococcus pneumoniae urinary antigen detection, sput

285 Current vaccination against Streptococcus pneumoniae uses vaccines based on capsular

286 er vaccination with the 13-valent-conjugated Streptococcus pneumoniae vaccine were assessed in a MAIT

287 n sub-Saharan Africa sub-optimally interrupt Streptococcus pneumoniae vaccine-serotype (VT) carriage

288 MRSA and 22 (1.0%) with MSSA; 115 (5.1%) had Streptococcus pneumoniae Vancomycin or linezolid was adm

289 orescently labeled Haemophilus influenzae or Streptococcus pneumoniae was assessed by fluorimetry.

290 he commensal genus Neisseria and the species Streptococcus pneumoniae was associated with lower EAC r

291 Streptococcus pneumoniae was cultured in 33 episodes (51

292 cost-effective assay to detect serotypes of Streptococcus pneumoniae, we developed a novel loop-medi

293 In Streptococcus pneumoniae, we find a genomically and ecol

294 lmonella enterica, Staphylococcus aureus and Streptococcus pneumoniae were also isolated.

295 Haemophilus influenzae and Streptococcus pneumoniae were the commonest bacterial pa

296 Haemophilus influenzae and Streptococcus pneumoniae were the main agents detected,

297 Haemophilus influenzae and Streptococcus pneumoniae were the prevalent isolates, an

298 subtilis and the heterodimer PatA/PatB from Streptococcus pneumoniae, when produced in several E. co

299 beta-lactam and co-trimoxazole resistance in Streptococcus pneumoniae with accuracies ranging from 88

300 ccus pyogenes, Streptococcus agalactiae, and Streptococcus pneumoniae with K(d) values of 0.6-4.6 uM.